UNSPSC 51131611: Dalteparin

This classification denotes a low molecular weight heparin with the molecular formula (C14H18NO11)N.2(C12H16NO13S)N.3HO3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S79O08V79F. European Medicines Agency schedules dalteparin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02475MIG. DALTEPARIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, DALTEPARIN remains the US FDA Preferred Term for this commodity.

Dalteparin bears US NLM identifiers UMLS ID C0206461 and NCI Concept Code C1453. SMILES: CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O.

UNSPSC 51131611 Dalteparin is a Commodity code that identifies a specific anticoagulant pharmaceutical product used in clinical and preventive care settings. However, the most recent state and local procurement activity posted under this code shows no relevant solicitations for dalteparin itself. Instead, the single recent opportunity tagged to this code—Sourcewell RFP #061626, posted May 12, 2026, with a response deadline of June 16, 2026—solicits Law Enforcement Equipment on behalf of a cooperative purchasing consortium spanning multiple states. This mismatch indicates that either the code assignment in the state and local procurement database is incorrect, or the opportunity was miscoded in the sourcing system. The nominal scope of the code—pharmaceutical anticoagulant procurement—does not align with the actual procurement being conducted.

State and local governments purchase dalteparin primarily through health departments, correctional facilities, public health clinics, emergency medical services, and hospital systems as part of routine pharmaceutical inventories and formulary management. Issuing bodies for pharmaceutical commodities typically include state departments of health, county public health agencies, and regional hospital or emergency services networks rather than the law enforcement agencies represented in the single recent opportunity. Without additional opportunities correctly coded to this Commodity code in the source, a meaningful geographic assessment or pattern of recent purchasing activity cannot be established. A business development professional should verify the correct UNSPSC code assignment with state and local procurement offices before pursuing opportunities in pharmaceutical anticoagulation therapy or should flag this code as showing minimal relevant recent activity pending recoding.